Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Fenestrated Endovascular Graft Repairs Aortic Aneurysms

By HospiMedica International staff writers
Posted on 03 Mar 2013
A customized endovascular stent graft can replace open invasive surgery in patients who have an abdominal aortic aneurysm (AAA) that involve the aorta and the iliac arteries.

The Zenith Fenestrated AAA Endovascular Graft is used to repair AAAs or aneurysms that involve both the abdominal aorta and the iliac arteries. More...
The new graft is similar to the traditional endovascular graft, made of a polyester fabric encased by a stainless steel scaffold. However, it is different from the off-the-shelf graft because of two fenestrations fabricated in the graft to accommodate the renal arteries, which help to keep the graft in place, as well as a scallop-shaped cut to supply blood to the superior mesenteric artery, which carries blood to the intestines.

The graft has three parts - an upper main body, a lower main body, and one leg. An adjunctive alignment stent made of stainless steel is used to help keep the holes in the graft lined up with the arteries that supply the organs. Patients eligible for the new customized graft repair include those whose aneurysms approach within 5 millimeters of the renal arteries, and have large enough vessels to deliver the stent-graft to the appropriate location. The planning process itself includes modeling the patient's aorta using computed tomography (CT), with fabrication of each graft taking about five weeks. The Zenith Fenestrated AAA Endovascular Graft is a product of Cook Medical (Bloomington, IN, USA).

“We do a substantial amount of planning before the endovascular operation to ensure that the graft will be engineered correctly to match the patient's individual anatomy,” said vascular surgeon James Black, MD, of Johns Hopkins Hospital (Baltimore, MD, USA). “At Hopkins, we perform close to 100 open abdominal aortic aneurysm repairs each year for patients who are not eligible for the minimally invasive option. With the new fenestrated stent-graft, we will be able to spare many of those patients a big operation and a long recovery.”

An AAA is a localized dilatation (ballooning) of the abdominal aorta exceeding the normal diameter by more than 50%, and is the most common form of aortic aneurysm. Approximately 90% of AAAs occur infrarenally, but they can also occur pararenally (at the level of the kidneys) or suprarenally. Such aneurysms can extend to include one or both of the iliac arteries in the pelvis. The major complication of AAAs is rupture, which is life-threatening, as large amounts of blood spill into the abdominal cavity, and can lead to death within minutes.]Mortality of rupture repair in the hospital is 60%–90%.

Related Links:
Cook Medical
Johns Hopkins Hospital


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.